2025-01-012025-12-312025-12-31falseSC491595HORIZON PROTEINS LIMITED2026-09-1574909falseiso4217:GBPxbrli:pureSC4915952024-12-31SC4915952025-12-31SC4915952025-01-012025-12-31SC4915952023-12-31SC4915952024-12-31SC4915952024-01-012024-12-31SC491595bus:SmallEntities2025-01-012025-12-31SC491595bus:AuditExempt-NoAccountantsReport2025-01-012025-12-31SC491595bus:FullAccounts2025-01-012025-12-31SC491595bus:PrivateLimitedCompanyLtd2025-01-012025-12-31SC491595core:WithinOneYear2025-12-31SC491595core:AfterOneYear2025-12-31SC491595core:WithinOneYear2024-12-31SC491595core:AfterOneYear2024-12-31SC491595core:ShareCapital2025-12-31SC491595core:SharePremium2025-12-31SC491595core:RevaluationReserve2025-12-31SC491595core:OtherReservesSubtotal2025-12-31SC491595core:RetainedEarningsAccumulatedLosses2025-12-31SC491595core:ShareCapital2024-12-31SC491595core:SharePremium2024-12-31SC491595core:RevaluationReserve2024-12-31SC491595core:OtherReservesSubtotal2024-12-31SC491595core:RetainedEarningsAccumulatedLosses2024-12-31SC491595core:LandBuildings2025-12-31SC491595core:PlantMachinery2025-12-31SC491595core:Vehicles2025-12-31SC491595core:FurnitureFittings2025-12-31SC491595core:OfficeEquipment2025-12-31SC491595core:NetGoodwill2025-12-31SC491595core:IntangibleAssetsOtherThanGoodwill2025-12-31SC491595core:ListedExchangeTraded2025-12-31SC491595core:UnlistedNon-exchangeTraded2025-12-31SC491595core:LandBuildings2024-12-31SC491595core:PlantMachinery2024-12-31SC491595core:Vehicles2024-12-31SC491595core:FurnitureFittings2024-12-31SC491595core:OfficeEquipment2024-12-31SC491595core:NetGoodwill2024-12-31SC491595core:IntangibleAssetsOtherThanGoodwill2024-12-31SC491595core:ListedExchangeTraded2024-12-31SC491595core:UnlistedNon-exchangeTraded2024-12-31SC491595core:LandBuildings2025-01-012025-12-31SC491595core:PlantMachinery2025-01-012025-12-31SC491595core:Vehicles2025-01-012025-12-31SC491595core:FurnitureFittings2025-01-012025-12-31SC491595core:OfficeEquipment2025-01-012025-12-31SC491595core:NetGoodwill2025-01-012025-12-31SC491595core:IntangibleAssetsOtherThanGoodwill2025-01-012025-12-31SC491595core:ListedExchangeTraded2025-01-012025-12-31SC491595core:UnlistedNon-exchangeTraded2025-01-012025-12-31SC491595core:MoreThanFiveYears2025-01-012025-12-31SC491595core:Non-currentFinancialInstruments2025-12-31SC491595core:Non-currentFinancialInstruments2024-12-31SC491595dpl:CostSales2025-01-012025-12-31SC491595dpl:DistributionCosts2025-01-012025-12-31SC491595core:LandBuildings2025-01-012025-12-31SC491595core:PlantMachinery2025-01-012025-12-31SC491595core:Vehicles2025-01-012025-12-31SC491595core:FurnitureFittings2025-01-012025-12-31SC491595core:OfficeEquipment2025-01-012025-12-31SC491595dpl:AdministrativeExpenses2025-01-012025-12-31SC491595core:NetGoodwill2025-01-012025-12-31SC491595core:IntangibleAssetsOtherThanGoodwill2025-01-012025-12-31SC491595dpl:GroupUndertakings2025-01-012025-12-31SC491595dpl:ParticipatingInterests2025-01-012025-12-31SC491595dpl:GroupUndertakingscore:ListedExchangeTraded2025-01-012025-12-31SC491595core:ListedExchangeTraded2025-01-012025-12-31SC491595dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2025-01-012025-12-31SC491595core:UnlistedNon-exchangeTraded2025-01-012025-12-31SC491595dpl:CostSales2024-01-012024-12-31SC491595dpl:DistributionCosts2024-01-012024-12-31SC491595core:LandBuildings2024-01-012024-12-31SC491595core:PlantMachinery2024-01-012024-12-31SC491595core:Vehicles2024-01-012024-12-31SC491595core:FurnitureFittings2024-01-012024-12-31SC491595core:OfficeEquipment2024-01-012024-12-31SC491595dpl:AdministrativeExpenses2024-01-012024-12-31SC491595core:NetGoodwill2024-01-012024-12-31SC491595core:IntangibleAssetsOtherThanGoodwill2024-01-012024-12-31SC491595dpl:GroupUndertakings2024-01-012024-12-31SC491595dpl:ParticipatingInterests2024-01-012024-12-31SC491595dpl:GroupUndertakingscore:ListedExchangeTraded2024-01-012024-12-31SC491595core:ListedExchangeTraded2024-01-012024-12-31SC491595dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2024-01-012024-12-31SC491595core:UnlistedNon-exchangeTraded2024-01-012024-12-31SC491595core:NetGoodwill2025-12-31SC491595core:IntangibleAssetsOtherThanGoodwill2025-12-31SC491595core:LandBuildings2025-12-31SC491595core:PlantMachinery2025-12-31SC491595core:Vehicles2025-12-31SC491595core:FurnitureFittings2025-12-31SC491595core:OfficeEquipment2025-12-31SC491595core:AfterOneYear2025-12-31SC491595core:WithinOneYear2025-12-31SC491595core:ListedExchangeTraded2025-12-31SC491595core:UnlistedNon-exchangeTraded2025-12-31SC491595core:ShareCapital2025-12-31SC491595core:SharePremium2025-12-31SC491595core:RevaluationReserve2025-12-31SC491595core:OtherReservesSubtotal2025-12-31SC491595core:RetainedEarningsAccumulatedLosses2025-12-31SC491595core:NetGoodwill2024-12-31SC491595core:IntangibleAssetsOtherThanGoodwill2024-12-31SC491595core:LandBuildings2024-12-31SC491595core:PlantMachinery2024-12-31SC491595core:Vehicles2024-12-31SC491595core:FurnitureFittings2024-12-31SC491595core:OfficeEquipment2024-12-31SC491595core:AfterOneYear2024-12-31SC491595core:WithinOneYear2024-12-31SC491595core:ListedExchangeTraded2024-12-31SC491595core:UnlistedNon-exchangeTraded2024-12-31SC491595core:ShareCapital2024-12-31SC491595core:SharePremium2024-12-31SC491595core:RevaluationReserve2024-12-31SC491595core:OtherReservesSubtotal2024-12-31SC491595core:RetainedEarningsAccumulatedLosses2024-12-31SC491595core:NetGoodwill2023-12-31SC491595core:IntangibleAssetsOtherThanGoodwill2023-12-31SC491595core:LandBuildings2023-12-31SC491595core:PlantMachinery2023-12-31SC491595core:Vehicles2023-12-31SC491595core:FurnitureFittings2023-12-31SC491595core:OfficeEquipment2023-12-31SC491595core:AfterOneYear2023-12-31SC491595core:WithinOneYear2023-12-31SC491595core:ListedExchangeTraded2023-12-31SC491595core:UnlistedNon-exchangeTraded2023-12-31SC491595core:ShareCapital2023-12-31SC491595core:SharePremium2023-12-31SC491595core:RevaluationReserve2023-12-31SC491595core:OtherReservesSubtotal2023-12-31SC491595core:RetainedEarningsAccumulatedLosses2023-12-31SC491595core:AfterOneYear2025-01-012025-12-31SC491595core:WithinOneYear2025-01-012025-12-31SC491595core:Non-currentFinancialInstrumentscore:CostValuation2025-01-012025-12-31SC491595core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2025-01-012025-12-31SC491595core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2025-01-012025-12-31SC491595core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2025-01-012025-12-31SC491595core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2025-01-012025-12-31SC491595core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2025-01-012025-12-31SC491595core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2025-01-012025-12-31SC491595core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2025-01-012025-12-31SC491595core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2025-01-012025-12-31SC491595core:Non-currentFinancialInstrumentscore:CostValuation2025-12-31SC491595core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2025-12-31SC491595core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2025-12-31SC491595core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2025-12-31SC491595core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2025-12-31SC491595core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2025-12-31SC491595core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2025-12-31SC491595core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2025-12-31SC491595core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2025-12-31SC491595core:Non-currentFinancialInstrumentscore:CostValuation2024-12-31SC491595core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2024-12-31SC491595core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2024-12-31SC491595core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2024-12-31SC491595core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2024-12-31SC491595core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2024-12-31SC491595core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2024-12-31SC491595core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2024-12-31SC491595core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2024-12-31SC491595bus:Director12025-01-012025-12-31SC491595bus:Director22025-01-012025-12-31SC491595bus:Director32025-01-012025-12-31

HORIZON PROTEINS LIMITED

Registered Number
SC491595
(Scotland)

Unaudited Financial Statements for the Year ended
31 December 2025

HORIZON PROTEINS LIMITED
Company Information
for the year from 1 January 2025 to 31 December 2025

Directors

LOCHHEAD, Iain Macgregor
WILLOUGHBY, Nicholas Allen, Dr
WINDING, Nicolai

Registered Address

Suite 2, Ground Floor Orchard Brae House
30 Queensferry Road
Edinburgh
EH4 2HS

Registered Number

SC491595 (Scotland)
HORIZON PROTEINS LIMITED
Statement of Financial Position
31 December 2025

Notes

2025

2024

£

£

£

£

Fixed assets
Intangible assets31,198,2551,145,976
Tangible assets4-73
1,198,2551,146,049
Current assets
Debtors5542,014569,542
Cash at bank and on hand77,678379,584
619,692949,126
Creditors amounts falling due within one year6(262,694)(500,026)
Net current assets (liabilities)356,998449,100
Total assets less current liabilities1,555,2531,595,149
Net assets1,555,2531,595,149
Capital and reserves
Called up share capital6,5426,542
Share premium2,756,9122,756,912
Profit and loss account(1,208,201)(1,168,305)
Shareholders' funds1,555,2531,595,149
The financial statements were approved and authorised for issue by the Board of Directors on 15 September 2026, and are signed on its behalf by:
LOCHHEAD, Iain Macgregor
Director
Registered Company No. SC491595
HORIZON PROTEINS LIMITED
Notes to the Financial Statements
for the year ended 31 December 2025

1.Accounting policies
Statutory information
The company is a private company limited by shares, registered in Scotland. The address of the registered office is Suite 2, Ground Floor, Orchard Brae House, 30 Queensferry Road, Edinburgh, EH4 2HS, United Kingdom.
Statement of compliance
These financial statements have been prepared in compliance with Section 1A of FRS 102, 'The Financial Reporting Standard applicable in the UK and the Republic of Ireland'.
Basis of preparation
The financial statements have been prepared on the historical cost basis. The financial statements are prepared in sterling, which is the functional currency of the entity.
Judgements and key sources of estimation uncertainty
The preparation of the financial statements requires management to make judgements, estimates and assumptions that affect the amounts reported. These estimates and judgements are continually reviewed and are based on experience and other factors, including expectations of future events that are believed to be reasonable under the circumstances.
Employee benefits
Short-term employee benefits are measured at the undiscounted amount expected to be paid in exchange for the employee's services to the company. Where employees have accrued short-term benefits which the entity has not paid by the balance sheet date, an accrual is recognised within creditors: amounts falling due within one year together with an associated expense in profit or loss. The liabilities are classified as current obligations in the statement of financial position because they are expected to be settled wholly within twelve months after the end of the period.
Defined contribution pension plan
Contributions to defined contribution plans are recognised as an expense in the period in which the related service is provided. Prepaid contributions are recognised as an asset to the extent that the prepayment will lead to a reduction in future payments or a cash refund. When contributions are not expected to be settled wholly within 12 months of the end of the reporting date in which the employees render the related service, the liability is measured on a discounted present value basis. The unwinding of the discount is recognised as a finance cost in profit or loss in the period in which it arises.
Deferred tax
Deferred tax is recognised in respect of all timing differences between the recognition of income and expenses in the financial statements and their inclusion in tax assessments. Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date and that are expected to apply to the reversal of the timing difference, except for revalued land and investment property where the tax rate that applies to the sale of the asset is used. Current and deferred tax assets and liabilities are not discounted.
Intangible assets
Development expenditure incurred on clearly defined projects whose outcome can be assessed with reasonable certainty is carried forward and amortisation is then charged when the products has reached a stage where it can achieve a sales value.
Tangible fixed assets and depreciation
Tangible assets are initially recorded at cost, and subsequently stated at cost less any accumulated depreciation and impairment losses. Any tangible assets carried at revalued amounts are recorded at the fair value at the date of revaluation less any subsequent accumulated depreciation and subsequent accumulated impairment losses. An increase in the carrying amount of an asset as a result of a revaluation, is recognised in other comprehensive income and accumulated in equity, except to the extent it reverses a revaluation decrease of the same asset previously recognised in profit or loss. A decrease in the carrying amount of an asset as a result of revaluation, is recognised in other comprehensive income to the extent of any previously recognised revaluation increase accumulated in equity in respect of that asset. Where a evaluation decrease exceeds the accumulated revaluation gains accumulated in equity in respect of that asset, the excess shall be recognised in profit or loss. Depreciation is calculated so as to write off the cost or valuation of an asset, less its residual value, over the useful economic life.

Straight line (years)
Vehicles25
Office Equipment33
Impairment of non-financial assets policy
A review for indicators of impairment is carried out at each reporting date, with the recoverable amount being estimated where such indicators exist. Where the carrying value exceeds the recoverable amount, the asset is impaired accordingly. Prior impairments are also reviewed for possible reversal at each reporting date. For the purposes of impairment testing, when it is not possible to estimate the recoverable amount of an individual asset, an estimate is made of the recoverable amount of the cash-generating unit to which the asset belongs. The cash-generating unit is the smallest identifiable group of assets that includes the asset and generates cash inflows that largely independent of the cash inflows from other assets or groups of assets. For impairment testing of goodwill, the goodwill acquired in a business combination is, from the acquisition date, allocated to each of the cash-generating units that are expected to benefit from the synergies of the combination, irrespective of whether other assets or liabilities of the company are assigned to those units.
Financial instruments
Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the entity after deducting all of its financial liabilities. Where the contractual obligations of financial instruments (including share capital) are equivalent to a similar debt instrument, those financial instruments are classed as financial liabilities. Financial liabilities are presented as such in the balance sheet. Finance costs and gains or losses relating to financial liabilities are included in the profit and loss account. Finance costs are calculated so as to produce a constant rate of return on the outstanding liability. Where the contractual terms of share capital do not have any terms meeting the definition of a financial liability then this is classed as an equity instrument. Dividends and distributions relating to equity instruments are debited direct to equity.
2.Average number of employees

20252024
Average number of employees during the year44
3.Intangible assets

Other

Total

££
Cost or valuation
At 01 January 251,145,9761,145,976
Additions52,27952,279
At 31 December 251,198,2551,198,255
Net book value
At 31 December 251,198,2551,198,255
At 31 December 241,145,9761,145,976
4.Tangible fixed assets

Vehicles

Office Equipment

Total

£££
Cost or valuation
At 01 January 2520,7987,59728,395
Disposals(20,798)-(20,798)
At 31 December 25-7,5977,597
Depreciation and impairment
At 01 January 2520,7987,52428,322
Charge for year-7373
On disposals(20,798)-(20,798)
At 31 December 25-7,5977,597
Net book value
At 31 December 25---
At 31 December 24-7373
5.Debtors: amounts due within one year

2025

2024

££
Other debtors542,014569,542
Total542,014569,542
6.Creditors: amounts due within one year

2025

2024

££
Trade creditors / trade payables55,141261,101
Other creditors103,567103,742
Accrued liabilities and deferred income103,986135,183
Total262,694500,026
7.Related party transactions
Their was no controlling party in the company throughout the year. No transactions with related parties were undertaken such as are required to be disclosed under FRS102.